DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2

By Bourne N.   Milligan G.N.   Schleiss M.R.   Bernstein D.I.   Stanberry L.R.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1230-1234

Elsevier

Access to resources Recommend Favorite

The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs

By McClements W.L.   Armstrong M.E.   Keys R.D.   Liu M.A.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 857-860

Elsevier

Access to resources Recommend Favorite

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

By Gebhard J.R.J.R.   Zhu J.   Cao X.   Minnick J.   Araneo A.B.A.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1837-1846

Elsevier

Access to resources Recommend Favorite

Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D

By Domingo C.   Gadea I.   Pardeiro M.   Castilla C.   Fernandez S.   Fernandez-Clua M.A.   De la Cruz Troca J.J.   Punzon C.   Soriano F.   Fresno M.   Tabares E.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3565-3574

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

By O'Hagan D.   Goldbeck C.   Ugozzoli M.   Ott G.   Burke R.L.  

Vaccine, Vol. 17, Iss. 18, 1999-05 ,pp. : 2229-2236

Elsevier

Access to resources Recommend Favorite